Amundi

Position in INSM — INSMED Inc

CIK 1330387 Paris, I0

Position in INSM

as of Mar 31, 2026 · filed May 18, 2026 Compact

Position Value

$131,629,838

-$27,964,493 QoQ

Shares Held

804,977

-12.2% QoQ

Ownership

0.371%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Amundi holds $2,277,505,863 across 70 Biotechnology names. INSM ranks #5 (5.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	1,009,798	$780,210,323
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,472,496	$657,528,360
3	ALNY	Alnylam Pharmaceuticals, Inc.	747,544	$247,339,881
4	RPRX	Royalty Pharma plc	3,088,773	$148,168,440
5	INSM	INSMED Inc This page	804,977	$131,629,838
6	INCY	Incyte Corp	1,003,969	$94,493,561
7	MRNA	Moderna, Inc.	904,823	$45,965,008
8	ARGX	Argenx SE	61,433	$44,861,448

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$131,629,838	804,977	-12.2%	Shares	Defined	2026-05-18
2025-12-31	$159,594,331	916,998	+189.2%	Shares	Defined	2026-02-17
2025-09-30	$45,664,994	317,096	+2657.6%	Shares	Defined	2025-11-14
2025-06-30	$1,157,259	11,499	+21194.4%	Shares	Defined	2025-08-13
2025-03-31	$4,119	54	+28.6%	Shares	Defined	2025-05-15
2024-12-31	$2,899	42	-99.1%	Shares	Defined	2025-02-07
2022-09-30	$105,933	4,918	0.0%	Shares	Defined	2022-11-14
2022-06-30	$96,982	4,918	0.0%	Shares	Defined	2022-09-02
2022-03-31	$115,573	4,918	0.0%	Shares	Defined	2022-05-16
2021-12-31	$133,966	4,918	-30.1%	Shares	Defined	2022-02-14
2021-09-30	$193,771	7,036	0.0%	Shares	Defined	2021-11-15
2021-06-30	$200,244	7,036	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.